Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.3, marking a -1.64% move from the…

INVESTOR ALERT: Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who:…

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead…

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims…

Hims & Hers Names Medical Chiefs for UK, EMEA and Australia

Hims & Hers Health has appointed Kultar Garcha, MD, as chief medical officer for the UK and EMEA and Matt...…

Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced two new clinical experts…

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC

ATLANTA, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek…

Hims & Hers appoints medical officers for UK and Australia

Hims & Hers appoints medical officers for UK and Australia…

Hims & Hers appoints medical officers for UK and Australia

Hims & Hers appoints medical officers for UK and Australia…

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc.

Hims & Hers Health (HIMS) Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit...…

Hims & Hers Goes Global - Renewed Growth Prospects With Margin Risks

International expansion and branded GLP-1 partnerships have accelerated Hims & Hers subscriber growth/cross-selling trends. Read why HIMS stock is a…

Redefining What Quality Care Means with Kultar Garcha, MD, Chief Medical Officer of the UK & EMEA

Hims & Hers named Kultar Garcha, MD, as Chief Medical Officer of the UK and EMEA. Hear from Dr. Garcha…

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership

Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG,…

Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.3, marking a -1.64% move from the…

HIMS ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE:…

Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.8% Rally? GF Value Says Undervalued

On September 30, 2026, Hims & Hers Health Inc (HIMS) shares rose 3.8% today, currently trading at $29.79. The stock…

Hims & Hers: U.S. Revenue Reacceleration Is Reassuring, And Valuation Compression Is Compelling (Upgrade)

Hims & Hers Health is upgraded to Buy as growth reaccelerates and valuation compresses. Click to read my analysis for…

Hims Stock Reclaims $30 and Attempts Breakout but Faces $35 Test

Hims & Hers shares are attempting to recover above $30, but the rebound remains tentative as buyers challenge the 50-day…

Hims & Hers Health Rallies as Investors Appear to Reassess Recent Selloff

Hims & Hers Health (HIMS) is up 7.0% today. Here is some analysis on what might have caused this price…

HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline

Hims & Hers Systems Shareholders Between August 4, 2025 and July 29, 2026 - Contact Bernstein Liebhard For More Information…

Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline November 2, 2026...…

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Hims & Hers Health (HIMS) Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit...…

HIMS boosts FY2026 revenue outlook with international expansion and GLP-1 partnerships despite margin pressure.

Hims & Hers Health (HIMS) has accelerated subscriber growth and cross-selling through international expansion and branded GLP-1 partnerships, leading to…

Hims & Hers upgraded to buy as revenue growth accelerates and valuation drops, signaling a strong entry point.

Hims & Hers has been upgraded to a buy rating due to its accelerating revenue growth and compressed valuation, making…

Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…

What Do Todays Market Moves Mean for Hims & Hers Health (NYSE:HIMS)?

Hims & Hers Health (NYSE:HIMS) enters today’s market discussion as sector themes, operations, and broader conditions draw attention.…

INVESTOR ALERT: Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims &…

Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem

Key Stats for HIMS Stock52-Week Range: $14 to $65Market Cap: around $6. 9 billionStreet Mean Target: around $31Forward 2-Year Revenue…

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead…

Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline November 2, 2026...…

Weekly Rundown: Abridge poised for broader VA expansion; Hims & Hers builds out AI-native care

Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief.…

dpa-AFX ProFeed